By Stephen Nakrosis
Repare Therapeutics on Monday said its Chief Financial Officer, Steve Forte, has been named as the company's president and chief executive officer, effective April 11.
He succeeds Lloyd Segal, who has resigned as president, CEO, and from the board to pursue other opportunities, Repare said.
Forte, who will continue to serve as CFO, will also join Repare's board.
Forte joined Repare Therapeutics in 2019 as executive vice president and CFO. Before that, he was CFO for Clementia Pharmaceuticals, during which Clementia was acquired by Ipsen for $1.3 billion, Repare said.
In after-hours trading, shares of the oncology company were up 4.5%, to $1.03. The stock has lost 79% over the last year.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
March 31, 2025 17:06 ET (21:06 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。